Product Name: MOG (63-83)
Product Number: PE-01AAA90
Size: | 200 µg | | Price: | 59.00 |
| 1 mg | | $US | 118.00 |
| 5 mg | | | 277.00 |
Peptide Name: MOG (63-83)
Product Use: This peptide can help to induce EAE (experimental autoimmune encephalomyelitis) in mice.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Mus musculus
Peptide Sequence: MEVGWYRSPFSRVVHLYRNGK
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2581.1 Da
Peptide Purity Percent after Synthesis and Purification: >90
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
References[1] Vittoria Simonini M, Polak PE, Boullerne AI, Peters JM, Richardson JC, Feinstein DL. Regulation of oligodendrocyte progenitor cell maturation by PPAR?: effects on bone morphogenetic proteins. ASN Neuro. 2010 Jan 15;2(1):e00025. PMID: 20001953.[2] Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol. 2002 Jun;51(6):694-702. PMID: 12112074.